The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia
<p>Abstract</p> <p>Background</p> <p>Finasteride, a 5 alpha reductase inhibitor, is an established treatment for benign prostatic hyperplasia. The recommended dosage is 5 mg a day, however case reports have show effectiveness with lower doses. The objective of the curre...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2002-01-01
|
| Series: | BMC Urology |
| Online Access: | http://www.biomedcentral.com/1471-2490/2/2 |